Please find below some of Dr Kanji's research
Research
Dr Kanji has several publications in peer-reviewed journals, and actively speaks at national and international conferences, including Diabetes Professional Care, Cardio Renal Metabolic UK Summit, EuroThrombosis EuroVessels and British Society for Haemostasis and Thrombosis.
Kanji R, Gue YX, Memtsas V, Spencer NH, Gorog DA. Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2023 May 16;81(19):1918-1932. doi: 10.1016/j.jacc.2023.03.388. PMID: 37164525.
https://pubmed.ncbi.nlm.nih.gov/37164525/
Kanji R, Gue YX, Farag MF, Spencer NH, Mutch NJ, Gorog DA. Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. JACC Basic Transl Sci. 2022 Aug 24;7(11):1069-1082. doi: 10.1016/j.jacbts.2022.05.007. PMID: 36687271; PMCID: PMC9849272.
https://pubmed.ncbi.nlm.nih.gov/36687271/
Kanji R, Leader J, Memtsas V, Gorog DA. Measuring Thrombus Stability at High Shear, Together With Thrombus Formation and Endogenous Fibrinolysis: First Experience Using the Global Thrombosis Test 3 (GTT-3). Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231181917. doi: 10.1177/10760296231181917. PMID: 37551011; PMCID: PMC10411283.
https://pubmed.ncbi.nlm.nih.gov/37551011/
Kanji R, Vandenbriele C, Arachchillage DRJ, Price S, Gorog DA. Optimal Tests to Minimise Bleeding and Ischaemic Complications in Patients on Extracorporeal Membrane Oxygenation. Thromb Haemost. 2022 Apr;122(4):480-491. doi: 10.1055/a-1508-8230. Epub 2021 Jun 21. PMID: 33984868.
https://pubmed.ncbi.nlm.nih.gov/33984868/
Kanji R, Gue YX, Memtsas V, Gorog DA. Fibrinolysis in Platelet Thrombi. Int J Mol Sci. 2021 May 12;22(10):5135. doi: 10.3390/ijms22105135. PMID: 34066261; PMCID: PMC8152010.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152010/
Kanji R, Jenner WJ, Mirsadraee S, Gue YX, Price S, Prasad S, Gorog DA. Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. J Thromb Thrombolysis. 2021 Apr;51(3):595-607. doi: 10.1007/s11239-021-02394-7. Epub 2021 Feb 14. PMID: 33586113; PMCID: PMC7882250.
https://pubmed.ncbi.nlm.nih.gov/33586113/
Kanji, R., Mirsadraee, S., Prasad, S., Gue, Y. X., Panoulas, V., & Gorog, D. A. Thrombosis Risk with Transcatheter Aortic Valve Replacement. Structural Heart. 2020 4(5), 349–359.
https://doi.org/10.1080/24748706.2020.1797256
Kanji R, Kubica J, Navarese EP, Gorog DA. Endogenous fibrinolysis-Relevance to clinical thrombosis risk assessment. Eur J Clin Invest. 2021 Apr;51(4):e13471. doi: 10.1111/eci.13471. Epub 2020 Dec 16. PMID: 33296082.
https://pubmed.ncbi.nlm.nih.gov/33296082/
Gue YX, Memtsas V, Kanji R, Wellsted DM, Busby A, Smith M, Vilar E, Ryding A, Arachchillage DJ, Gorog DA. Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study. Thromb Res. 2024 Apr;236:144-154. doi: 10.1016/j.thromres.2024.02.030. Epub 2024 Mar 3. PMID: 38447421.
https://pubmed.ncbi.nlm.nih.gov/38447421/
Leader JH, Kanji R, Gorog DA. Spontaneous reperfusion in STEMI: Its mechanisms and possible modulation. Kardiol Pol. 2024;82(4):363-374. doi: 10.33963/v.phj.99737. Epub 2024 Mar 17. PMID: 38493469.
https://pubmed.ncbi.nlm.nih.gov/38493469/
Gue YX, Kanji R, Wellsted DM, Srinivasan M, Wyatt S, Gorog DA. Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. J Thromb Thrombolysis. 2020 Feb;49(2):192-198. doi: 10.1007/s11239-019-02014-5. PMID: 31872349; PMCID: PMC6969858.
https://pubmed.ncbi.nlm.nih.gov/31872349/
Gue YX, Kanji R, Gati S, Gorog DA. MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment. Eur Cardiol. 2020 Apr 30;15:e20. doi: 10.15420/ecr.2019.13. PMID: 32419851; PMCID: PMC7215489.
https://pubmed.ncbi.nlm.nih.gov/32419851/
Kanji R, Dinarvand D, Gue YX, Gorog DA. Myocardial infarction with non-obstructive coronary arteries in young women presenting with ST-segment elevation myocardial infarction: a case series. Medical Research Journal 2020;5(1):55-60.
https://journals.viamedica.pl/medical_research_journal/article/view/67839
Gue YX, Sayers M, Whitby BT, Kanji R, Adatia K, Smith R, Davies WR, Perperoglou A, Potpara TS, Lip GYH, Gorog DA. Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest. Am J Med. 2020 Nov;133(11):1328-1335. doi: 10.1016/j.amjmed.2020.03.046. Epub 2020 May 7. PMID: 32387318.
https://pubmed.ncbi.nlm.nih.gov/32387318/
Gue YX, Adatia K, Kanji R, Potpara T, Lip GYH, Gorog DA. Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival. Am Heart J. 2021 Apr;234:31-41. doi: 10.1016/j.ahj.2020.12.011. Epub 2020 Dec 31. PMID: 33387469.
https://pubmed.ncbi.nlm.nih.gov/33387469/
Gue YX, Kanji R, Markides V, Gorog DA. Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19. Am J Cardiol. 2020 Sep 1;130:161-162. doi: 10.1016/j.amjcard.2020.06.002. Epub 2020 Jun 9. PMID: 32636018; PMCID: PMC7282749.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282749/
Gue YX, Tennyson M, Gao J, Ren S, Kanji R, Gorog DA. Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. Sci Rep. 2020 Dec 7;10(1):21379. doi: 10.1038/s41598-020-78505-w. Erratum in: Sci Rep. 2021 Apr 7;11(1):8011. doi: 10.1038/s41598-021-87439-w. PMID: 33288840; PMCID: PMC7721695.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721695/
Barbero U, Kanji R, Cerrato E, Di Summa R, Conrotto F, Kawamoto H, Biondi-Zoccai G, Gili S, Ugo F, Iannaccone M, Gagliardi M, De Benedictis M, Doronzo B, Varbella F, D'Amico M, Moretti C, Colombo A, Escaned J, D'Ascenzo F. Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. J Invasive Cardiol. 2018 Aug;30(8):283-288. Epub 2018 May 15. PMID: 29760284.
https://pubmed.ncbi.nlm.nih.gov/29760284/
Barbero U, D'Ascenzo F, Campo G, Kleczyński P, Dziewierz A, Menozzi M, Jiménez Díaz VA, Cerrato E, Raposeiras-Roubín S, Ielasi A, Rognoni A, Fineschi M, Kanji R, Jaguszewski MJ, Picchi A, Andò G, Soraci E, Mancone M, Sardella G, Calcagno S, Gallo F, Huczek Z, Krakowian M, Verardi R, Montefusco A, Omedè P, Lococo M, Moretti C, D'Amico M, Rigattieri S, Gaita F, Rinaldi M, Escaned J. Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol. 2018 Nov 1;270:107-112. doi: 10.1016/j.ijcard.2018.06.013. Epub 2018 Jun 8. PMID: 29937300.
https://pubmed.ncbi.nlm.nih.gov/29937300/
Kanji R, Gue YX, Dinarvand D, Farag MQ, Gorog DA, Assessment of endogenous fibrinolysis using a point-of-care assay to identify increased cardiovascular risk in patients with diabetes and ACS. European Heart Journal. Volume 41, Issue Supplement_2, November 2020, ehaa946.1540
https://doi.org/10.1093/ehjci/ehaa946.1540
R Kanji, Y.X Gue, D Dinarvand, D.A Gorog, No difference in thrombotic profile of patients with ACS with obstructive CAD and MINOCA. European Heart Journal. Volume 41, Issue Supplement_2, November 2020, ehaa946.1541
https://doi.org/10.1093/ehjci/ehaa946.1541management.